Algert Global LLC increased its stake in shares of Kodiak Sciences Inc. (NASDAQ: KOD) by 26.1% durin

This whale alert can help traders discover the next big trading opportunities. Whales are entities w

HC Wainwright & Co. analyst Matthew Caufield reiterates Kodiak Sciences (NASDAQ:KOD) with a B

KOD's Zenkuda advances toward regulatory submission as its pipeline gains momentum. Key clinical dat

Kodiak Sciences (NASDAQ:KOD) reported quarterly losses of $(1.05) per share which missed the analyst

PALO ALTO, Calif., Aug. 13, 2026 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), today reported

Kodiak launches a global phase III study of KSI-501 in DME, testing its dual IL-6 and VEGF approach

Phase 3 ALTO trial designed to demonstrate superiority of KSI-501 versus aflibercept in patients wit

Phase 3 ALTO trial designed to demonstrate superiority of KSI-501 versus aflibercept in patients wit

First pivotal cohort enrolled 300 subjects, with topline clinical data from 24-week primary endpoint

JP Morgan analyst Anupam Rama maintains Kodiak Sciences (NASDAQ:KOD) with a Overweight and raises

Shares of Kodiak Sciences Inc. (NASDAQ: KOD - Get Free Report) shot up 6.6% on Friday. The company t

Apogee Enterprises Inc (NASDAQ: APOG) rose sharply after the company reported better-than-expected f

Kodiak Sciences (KOD) is transitioning from past clinical disappointments to a maturing retina platf

This clinical-stage biotech focused on retinal therapies reported a notable insider sale amid a year

KOD surges on positive phase III Zenkuda data, accelerated regulatory plans, advancing late-stage pr

PALO ALTO, Calif., May 28, 2026 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a precommercial

This clinical-stage biotech develops innovative retinal disease therapies, with its lead candidate a

Top analysts upgraded Starz Entertainment, Primoris Services, Pitney Bowes, Kodiak Sciences, and Sta

KOD posts a wider Q1 loss as research & development spending rises, while positive phase III Zenkuda

PALO ALTO, Calif., May 7, 2026 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), today reported re

Clinical results of KSI-101 in macular edema secondary to inflammation (MESI) from a tertiary care u

Kodiak Sciences (KOD) reported earnings 30 days ago. What's next for the stock?

The small-cap Russell 2000 punched through to an intraday record high on Friday, capping a furious 1

KOD posts wider Q4 loss. However, its pipeline advances, with strong phase III data for Zenkuda driv

U.S. stocks rise, Dow Jones up 400+ points. PVH Corp beats expectations, shares jump 9.9%. Other big

PALO ALTO, Calif., March 31, 2026 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), today reported

Kodiak Sciences' stock (NASDAQ: KOD) experienced a substantial 62% surge last week, elevating the st

Kodiak Sciences Inc. (NASDAQ: KOD - Get Free Report) shares hit a new 52-week high during trading on

U.S. stocks lower, Nasdaq falls 1%. Oxford Industries up 11.2% on strong earnings, raised dividend.

The U.S. trade deficit in goods shrank to $87.3 billion in February from $88.6 billion in January, w

Olaplex Holdings shares surge 51% after being acquired by Henkel AG & Co. KGaA. Other big gainer

Dow and NASDAQ down over 0.5%, S&P 500 down 0.82%. Energy shares up, communication services down

U.S. stocks were lower, with the Nasdaq Composite falling more than 100 points on Thursday.

Kodiak Sciences posted a second-quarter loss of $1.03 per share, compared to market estimates of a l